The natural product 'K-26'from an actinomycete is representative of an uninvestigated class of natural carbon-phosphorus bond containing compounds which incorporate a phosphonic acid analog of tyrosine. K- 26 possesses angiotensin converting enzyme (ACE) inhibitory activity with an IC50 value of 12.5 nM, comparable to the widely prescribed antihypertensive drug Captopril. K-26 is comprised of N-acetylated isoleucine, tyrosine, and the nonproteinogenic amino acid, (R)-1-amino-2-(4-hydroxyphenyl)ethylphosphonic acid (AHEP). Despite the potent hypotensive activity of K-26 and related compounds, the biosynthetic pathways by which K-26 and more specifically AHEP are biosynthesized still remain uncharacterized. The aromatic amino acid functionality of AHEP suggests that its origin lies in the shikimic acid pathway. However, it is difficult to rationalize how phosphoenolpyruvate mutase, the activity responsible for forming all previously studied phosphonate containing natural products, can be integrated into classical amino acid metabolism to generate AHEP. We describe preliminary data that demonstrate that AHEP is derived from tyrosine and that the C-P bond forming chemistry is unique. We hypothesize a mechanism for C-P bond formation and propose a series of studies to (1) define the basic building blocks and pathway of assembly of K-26, (2) identify the genes responsible for K-26 biosynthesis and (3) characterize the K-26 biosynthetic machinery, especially the C-P bond forming biochemistry. Impact on public health: Proposed research will be the first study of the biosynthesis of a unique class of compounds containing an aromatic phosphonic acid, a class which has been demonstrated to have potent metalloproteinase inhibitory activity. As such, this proposal will provide significant new tools for the discovery and recombinant biocatalytic generation of therapeutically useful novel phosphonate functional metalloproteinase inhibitors. Metalloproteinase inhibitors have potential to treat a large number of human illnesses including hypertension, cancer and osteoarthritis, among others.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM077189-05
Application #
7790655
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Jones, Warren
Project Start
2006-04-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2012-03-31
Support Year
5
Fiscal Year
2010
Total Cost
$221,038
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Biochemistry
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Kramer, Glenna J; Mohd, Akif; Schwager, Sylva L U et al. (2014) Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes. ACS Med Chem Lett 5:346-51
Birmingham, William R; Starbird, Chrystal A; Panosian, Timothy D et al. (2014) Bioretrosynthetic construction of a didanosine biosynthetic pathway. Nat Chem Biol 10:392-9
Iverson, T M; Panosian, Timothy D; Birmingham, William R et al. (2012) Molecular differences between a mutase and a phosphatase: investigations of the activation step in Bacillus cereus phosphopentomutase. Biochemistry 51:1964-75
Nannemann, David P; Birmingham, William R; Scism, Robert A et al. (2011) Assessing directed evolution methods for the generation of biosynthetic enzymes with potential in drug biosynthesis. Future Med Chem 3:809-19
Panosian, Timothy D; Nannemann, David P; Watkins, Guy R et al. (2011) Bacillus cereus phosphopentomutase is an alkaline phosphatase family member that exhibits an altered entry point into the catalytic cycle. J Biol Chem 286:8043-54
Panosian, Timothy D; Nannemann, David P; Bachmann, Brian O et al. (2010) Crystallization and preliminary X-ray analysis of a phosphopentomutase from Bacillus cereus. Acta Crystallogr Sect F Struct Biol Cryst Commun 66:811-4
Bachmann, Brian O (2010) Biosynthesis: is it time to go retro? Nat Chem Biol 6:390-3
Nannemann, David P; Kaufmann, Kristian W; Meiler, Jens et al. (2010) Design and directed evolution of a dideoxy purine nucleoside phosphorylase. Protein Eng Des Sel 23:607-16
Vey, Jessica L; Al-Mestarihi, Ahmad; Hu, Yunfeng et al. (2010) Structure and mechanism of ORF36, an amino sugar oxidizing enzyme in everninomicin biosynthesis . Biochemistry 49:9306-17
Phelan, Vanessa V; Du, Yu; McLean, John A et al. (2009) Adenylation enzyme characterization using gamma -(18)O(4)-ATP pyrophosphate exchange. Chem Biol 16:473-8

Showing the most recent 10 out of 14 publications